Primary refractory plasmablastic lymphoma: A precision oncology approach

INTRODUCTION: Hematologic malignancies are currently underrepresented in multidisciplinary molecular-tumor-boards (MTB). This study assesses the potential of precision-oncology in primary-refractory plasmablastic-lymphoma (prPBL), a highly lethal blood cancer. METHODS: We evaluated clinicopathologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Witte, Hanno M., Fähnrich, Anke, Künstner, Axel, Riedl, Jörg, Fliedner, Stephanie M. J., Reimer, Niklas, Hertel, Nadine, von Bubnoff, Nikolas, Bernard, Veronica, Merz, Hartmut, Busch, Hauke, Feller, Alfred, Gebauer, Niklas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008852/
https://www.ncbi.nlm.nih.gov/pubmed/36923431
http://dx.doi.org/10.3389/fonc.2023.1129405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008852/
https://www.ncbi.nlm.nih.gov/pubmed/36923431
http://dx.doi.org/10.3389/fonc.2023.1129405

Ejemplares similares